We are so excited to work with Boston Scientific on a project like this. — Rich Adcock chief innovation officer at Sanford Health
Sioux Falls, S.D. (PRWEB)
May 30, 2017
Patrick Kelly, M.D., with Sanford Vascular Innovations, a division of Sanford Health, will collaborate with Boston Scientific, a global medical technology leader, to develop a device that could transform treatment for life-threatening blood clots in the lungs, known as pulmonary embolisms.
Dr. Kelly has invented a less-invasive catheter system for treating a pulmonary embolism or blood clots in the lungs.
A blood clot in the lung can restrict blood flow, which in turn decreases oxygen levels in the blood and can affect other organs. Large or multiple clots can be fatal. They are most common after surgery, trauma or periods of prolonged immobility. They also are common in pregnant women and older patients.
“Dr. Kelly cares about keeping his patients independent and ambulatory. That’s why he’s worked so tirelessly to find a new treatment for them,” said Rich Adcock, chief innovation officer at Sanford Health. “We are so excited to work with Boston Scientific on a project like this – and, ultimately, to make a difference for our patients.”
Sanford Health and Boston Scientific are working to develop and optimize the catheter’s design. The process of bringing a device like this to market can take many years – from engineering and design to clinical trials and finally FDA approval. “Engaging in collaborative partnerships with physicians, like Dr. Kelly, allows Boston Scientific to accelerate the pace of innovation in solving unmet clinical needs – ultimately influencing lower costs and better outcomes for patient care,” said Jeff Mirviss, president of peripheral interventions at Boston Scientific.